All posts in
German Researchers use SynBio to Brew Renewable Fatty Acids
German Biotech closes Largest Series A Fundraising of 2017 So Far
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
German Spin-off Scores Funding to Treat Atrial Fibrillation
Dutch and German Biotechs enter the Clinic with their First Lanthipeptide
UPDATE: More Promising Results from Mologen’s New HIV Therapy
Which European Country is Winning the Race in Clinical Development?
Germany gains Strength in Allergy Immunotherapeutics
German Biotech gets Seed Funding to Repurpose Cancer Drugs for the Flu
Could GM Insects impact the international trade of Organic Food?
Meet these 3 Exciting German Startups Pitching in Aachen Today!
Young German Immune Therapy Biotech expands its Series A Funding
Labiotech UG, All Rights Reserved -
Send this to friend